SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-22-002264
Filing Date
2022-01-07
Accepted
2022-01-07 16:11:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 F-1 tm221485-1_f1.htm F-1 637923
2 EXHIBIT 5.1 tm221485d2_ex5-1.htm EX-5.1 30445
3 EXHIBIT 23.3 tm221485d2_ex23-3.htm EX-23.3 2110
4 EXHIBIT 23.4 tm221485d2_ex23-4.htm EX-23.4 3504
5 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22587
6 GRAPHIC tm2131908d1-tbl_inter4clr.jpg GRAPHIC 90565
7 GRAPHIC tm2131908d1-tbl_exter14clr.jpg GRAPHIC 95719
8 GRAPHIC tm2131908d1-tbl_mate4clr.jpg GRAPHIC 146968
9 GRAPHIC tm2131908d1-tbl_early4clr.jpg GRAPHIC 102410
10 GRAPHIC tm221485d1_ex5-1img02.jpg GRAPHIC 4677
11 GRAPHIC tm221485d1_ex5-1img01.jpg GRAPHIC 1306
  Complete submission text file 0001104659-22-002264.txt   1315446
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-262050 | Film No.: 22518262
SIC: 2834 Pharmaceutical Preparations